SCHEMBL9059848

SCHEMBL9059848

CC(=N)Nc1ccccc1N1CCOSC1.CSCc1ccc(NC(C)=N)c(N2CCOCC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
MCOLN3 Q8TDD5 1/20 0.44
KMT2A Q03164 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 5/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RECQL P46063 1/20 0.41
ATM Q13315 1/20 0.40
TSHR P16473 2/20 0.40
GPR55 Q9Y2T6 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 1/20 0.40
MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9424131 0.86 POLB (0.47) LMNAGAAMCOLN3KMT2ANPC1
SCHEMBL9424584 0.82 KMT2A (0.41) LMNAGAAMCOLN3KMT2ANPC1
SCHEMBL9059942 0.76 ALDH1A1 (0.59) LMNAGAAMCOLN3KMT2ANPC1
SCHEMBL9555520 0.76 ALDH1A1 (0.40) LMNAGAAMCOLN3KMT2ANPC1
Iodide SCHEMBL9423992 0.75 ALDH1A1 (0.39) LMNAGAAMCOLN3KMT2ANPC1
SCHEMBL9059090 0.70 POLB (0.44) LMNAKMT2ANPC1ALDH1A1POLB
SCHEMBL9424727 0.69 ALDH1A1 (0.56) LMNAGAAMCOLN3KMT2AALDH1A1
Iodide SCHEMBL9423963 0.68 ALDH1A1 (0.55) LMNAGAAMCOLN3KMT2AALDH1A1
SCHEMBL9064067 0.68 KMT2A (0.55) KMT2ARAB9AALDH1A1CYP1A2CYP3A4
SCHEMBL9059191 0.67 SMN1; SMN2 (0.47) GAAKMT2ANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed